Therapeutic Drug Monitoring (TDM) Market: By Drug Type (Antibiotics, Addiction Therapeutics, Alzheimer Disease, Analeptics, Analgesics, Antiarrhythmic, Anticancer, Anticoagulants, Antidepressants, Antiepileptics, Anti-HIV, Antihypertensive, Antipsychotics, Hormones, Immuno-Suppressants, Antifungals), By Technology (Immuno- Assay, Mass Spectrometry, GC-MS/MS, Others), By End User (Hospital Laboratories, Private Laboratories) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Therapeutic Drug Monitoring Market size was valued at USD x billion in 2022 and is poised to grow at a CAGR of x% from 2023-29.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Therapeutic Drug Monitoring Market 2 Segmentation

By Drug Type
  • Antibiotics, Addiction Therapeutics,
  • Alzheimer Disease,
  • Analeptics,
  • Analgesics,
  • Antiarrhythmic,
  • Anticancer,
  • Anticoagulants,
  • Antidepressants,
  • Antiepileptics,
  • Anti-HIV,
  • Antihypertensive,
  • Antipsychotics,
  • Hormones,
  • Immuno-Suppressants,
  • Antifungals
By Technology
  • Immuno- Assay,
  • Mass Spectrometry,
  • GC-MS/MS,
  • Others
By End User
  • Hospital Laboratories,
  • Private Laboratories

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive Summary
2. Global Therapeutic Drug Monitoring (TDM) Market Introduction
2.1. Global Therapeutic Drug Monitoring (TDM) Market – Taxonomy
2.2. Global Therapeutic Drug Monitoring (TDM) Market –Definitions
2.2.1. Drug Type
2.2.2. Technology
3. Global Therapeutic Drug Monitoring (TDM) Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Microbial Derived Products Market Dynamic Factors - Impact Analysis
3.6. Impact of COVID 19 on The Market
3.7. Three Forecast Scenarios - Pessimistic, Conservative, and Opportunistic
3.8. Mapping Market Player’s Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations, and Mergers
3.12. Epidemilogy
3.13. PEST Analysis
3.14. PORTER's Analysis
4. Global Antibiotics Therapeutic Drug Monitoring (TDM) Market, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.1. Chloramphenicol
4.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.2. Linezolid
4.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.3. Piperacillin
4.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.3.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.3.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.4. Rifampicin
4.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.4.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.4.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.5. Tazobactam
4.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.5.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.5.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.6. Vancomycin
4.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.6.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.6.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.7. Gentamicin
4.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.7.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.7.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.8. Amikacin
4.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.8.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.8.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.9. Tobramycin
4.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.9.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.9.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.10. Meropenem
4.10.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.10.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.10.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.11. Naficillin
4.11.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.11.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
4.11.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
5. Global Addiction Therapeutics Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 – 2029 (Revenue, USD Mn)
5.1. Buprenorphine
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
5.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
5.2. Methadone
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
5.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
5.3. Naltrexone
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
5.3.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
5.4. Tapentadol
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
5.4.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
5.5. Others
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
5.5.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
6. Global Analgesics Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. Paracetamol
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
6.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
6.2. Ibuprofen
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
6.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
6.3. Naproxen
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
6.3.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
6.4. Aspirin
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
6.4.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
6.5. Tramadol
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
6.5.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7. Global Anticancer Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. 5-Fluorouracil
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.2. Docetaxel
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.3. Methotrexate
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.3.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.4. Paclitaxel
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.4.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.5. Imatinib
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.5.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.6. Busulfan
7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.6.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
7.6.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
8. Global Alzheimer’s Disease Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 – 2029 (Revenue, USD Mn)
8.1. Donepezil
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
8.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
8.2. Galantamine
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
8.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
8.3. Memantine
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
8.3.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
9. Global Analeptics Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. Caffeine
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
9.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
9.2. Theophylline
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
9.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10. Global Antiarrhythmic Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Amiodarone
10.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.2. Digoxin
10.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.3. Flecainide
10.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.3.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.3.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.4. Mexiletine
10.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.4.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.4.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.5. Verapamil
10.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.5.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.5.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.6. Digitoxin
10.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.6.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.6.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.7. Lidocaine
10.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.7.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
10.7.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
11. Global Anticoagulants Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Dabigatran
11.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
11.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
11.2. Warfarin
11.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
11.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
12. Global Antihypertensive Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Propranolol
12.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
12.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13. Global Antidepressant Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Citalopram
13.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.2. Fluoxetine
13.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.3. Fluvoxamine
13.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.3.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.3.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.4. Sertraline
13.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.4.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.4.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.5. Venlafaxine
13.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.5.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.5.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.6. Trazodone 
13.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.6.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.6.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.7. Protriptyline 
13.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.7.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.7.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.8. Nortriptyline
13.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.8.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.8.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.9. Imipramine
13.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.9.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.9.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.10. Desipramine
13.10.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.10.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.10.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.11. Doxepin
13.11.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.11.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.11.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.12. Clomipramine
13.12.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.12.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.12.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.13. Bupropion
13.13.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.13.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.13.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.14. Amitriptyline
13.14.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.14.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
13.14.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14. Global Antiepileptic Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.1. Ethosuximide
14.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.2. Felbamate
14.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.3. Gabapentin
14.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.3.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.3.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.4. Lamotrigine
14.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.4.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.4.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.5. Pregabaline
14.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.5.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.5.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.6. Topiramate
14.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.6.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.6.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.7. Zonisamide
14.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.7.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.7.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.8. Carbamazepine
14.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.8.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.8.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.9. Valproic Acid
14.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.9.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.9.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.10. Lacosamide
14.10.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.10.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.10.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.11. Levetiracetam
14.11.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.11.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.11.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.12. Phenobarbital
14.12.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.12.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.12.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.13. Phenytoin
14.13.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.13.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.13.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.14. Rufinamide
14.14.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.14.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.14.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.15. Tiagabine
14.15.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.15.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.15.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.16. Vigabatrin
14.16.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.16.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
14.16.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15. Global Anti-HIV Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.1. Atazanavir
15.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.2. Indinavir
15.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.3. Lopinavir
15.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.3.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.3.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.4. Nelfinavir
15.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.4.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.4.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.5. Ritonavir
15.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.5.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.5.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.6. Saquinavir
15.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.6.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.6.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.7. Darunavir
15.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.7.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.7.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.8. Fosamprenavir
15.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.8.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.8.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.9. Tipranavir
15.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.9.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.9.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.10. Efavirenz
15.10.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.10.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.10.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.11. Etravirine
15.11.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.11.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.11.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.12. Nevirapine
15.12.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.12.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.12.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.13. Rilpivirine
15.13.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.13.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
15.13.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16. Global Psychotic Drugs Therapeutic Drug Monitoring (TDM) Market Forecast, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
16.1. Aripiprazole
16.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
16.1.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.1.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.2. Clozapine
16.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
16.2.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.2.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.3. Haloperidol
16.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
16.3.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.3.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.4. Olanzapine
16.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
16.4.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.4.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.5. Ziprasidone
16.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
16.5.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.5.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.6. Chlorpromazine
16.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
16.6.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.6.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.7. Lithium
16.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
16.7.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.7.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.8. Lurasidone
16.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
16.8.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.8.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.9. Paliperidone
16.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
16.9.2. Technology Analysis (Value and Volume), 2018-2022 and Forecast 2023 - 2029 
16.9.3. Regional Analysis (Value and Volume), 2018-2022 and Forecast 2